https://xcube.bio/
xcube.bio | Market-entry accelerator for innovative biopharmas
Aug 29, 2025 - Boost value by looking beyond approval. We incubate your commercial expansion ex-US, taking the early risk and delivering full operations
market entry acceleratorbioinnovative
https://pro.thestreet.com/trade-ideas/i-have-a-prescription-for-these-two-biopharmas-that-fell-after-earnings
I Have a Prescription for These Two Biopharmas That Fell After Earnings | TheStreet Pro
Ardelyx and Syndax Pharmaceuticals slipped after posting first-quarter results and here's why I see them a medicine for my portfolio.
i have a prescription
https://www.ey.com/en_ae/insights/life-sciences/how-biopharmas-can-create-long-term-growth-focusing-on-sustainability
How biopharmas can create long-term growth focusing on sustainability | EY - MENA
In health care, there is a growing need to embed the perspectives of diverse stakeholders in the sustainability agenda.
long term